Breast Cancer Clinical Trial

Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins

Summary

The goal of this research study is to determine if we can obtain personalized genetic information from a subject's blood sample that is similar to that obtained from a tumor tissue sample, and if we can use that information to make treatment suggestions.

View Full Description

Full Description

The goal of this research study is to determine if we can obtain personalized genetic information from a subject's blood sample that is similar to that obtained from a tumor tissue sample, and if we can use that information to make treatment suggestions. As tumor samples can be difficult to collect, we hope to be able to collect similar genetic information from blood or urine samples that we find in tumor tissue. Ultimately, we hope to identify genes important to cancer cells that could potentially identify standard-of-care or research-based recommendations for therapy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Male or Female
18 years of age or older
Metastatic breast cancer and treatment with prior chemotherapy
Any clinical phenotype (Triple negative, Hormone receptor positive, human epidermal growth factor receptor 2 (HER2)-positive)
Patient must have received a metastatic tumor biopsy within 3 years prior to the date of the first planned blood sample for the study and have tissue available from this biopsy
Able to voluntarily provide informed consent

Exclusion Criteria:

Women who are pregnant or nursing

Study is for people with:

Breast Cancer

Estimated Enrollment:

200

Study ID:

NCT02965755

Recruitment Status:

Recruiting

Sponsor:

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore Maryland, 21287, United States More Info
Hopkins Breast Trials
Contact
410-614-1361
[email protected]
Kimmel Cancer Center Clinical Research Office
Contact
410-955-8866
[email protected]
Vered Stearns, M.D.
Principal Investigator
Allegheny Health Network Cancer Institute
Pittsburgh Pennsylvania, 15212, United States More Info
Larisa Greenberg
Contact
Larisa Greenberg
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

200

Study ID:

NCT02965755

Recruitment Status:

Recruiting

Sponsor:


Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider